Greeley, CONCT05863351Now EnrollingIRB Ready

Kidney Cancer Clinical Trial in Greeley, CO

Access cutting-edge kidney cancer treatment through this clinical trial at a research site in Greeley. Study-provided care at no cost to qualified participants.

Sponsored by ECOG-ACRIN Cancer Research Group

Quick Self-Assessment

See if you qualify for this Greeley location

Preparing your pre-screening questions...

Expert Care in Greeley

Access kidney cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kidney cancer treatment provided free

Apply for This Greeley Location

Check if you qualify for this kidney cancer clinical trial in Greeley, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Greeley

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Greeley site if eligible
  4. 4Begin participation

About This Kidney Cancer Study in Greeley

This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get

Sponsor: ECOG-ACRIN Cancer Research Group

Who Can Participate

Inclusion Criteria

Patient must be \>= 18 years of age
Patient must have a pathologically (histologically or cytologically) proven diagnosis of renal cell carcinoma (RCC) prior to randomization
Patient may have any RCC histology except a histology that has a sarcomatoid component
Patient must have primary site addressed by local therapy. If the primary RCC is intact, the patient must undergo local treatment to the primary before randomization
Patient must have favorable or intermediate International Metastatic RCC Database Consortium (IMDC) risk (0-2) at the time of randomization
Patient must have a total of between 2 and 5 metastatic lesions, as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria with imaging obtained within 45 days prior to randomization
Patient must have a documentation from a radiation oncologist confirming that all sites are amenable to SAbR
Patient may have received prior therapy in the adjuvant setting as long as potential

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Greeley?

Yes, this clinical trial (NCT05863351) has an active research site in Greeley, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Kidney Cancer Treatment Options in Greeley, CO

If you're searching for kidney cancer treatment options in Greeley, CO, this clinical trial (NCT05863351) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Greeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kidney cancer clinical trials near you to find additional studies recruiting in your area.

More Kidney Cancer Trials in Greeley, CO

See all kidney cancer clinical trials recruiting in Greeley — not just this study.

Browse Kidney Cancer Trials in Greeley

Browse More Trials by Condition

Ready to Join in Greeley?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Greeley, CO